Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
2.690
+0.010 (0.37%)
Aug 1, 2025, 4:00 PM - Market closed
ATSG Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for ATSG.
Price Target: $0.00 (0.00%)
Analyst Consensus: Buy
Analyst Ratings
According to 1 stock analyst, the rating for ATSG is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jun '25 | Jul '25 |
---|---|---|
Strong Buy | 0 | 0 |
Buy | 1 | 1 |
Hold | 0 | 0 |
Sell | 0 | 0 |
Strong Sell | 0 | 0 |
Total | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 8, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.19
from -10.44
EPS Next Year
-2.35
from -3.19
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | n/a | n/a | 84.0M |
Avg | n/a | n/a | 40.8M |
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -2.64 | -2.21 | 0.89 |
Avg | -3.19 | -2.35 | 0.87 |
Low | -3.68 | -2.45 | 0.83 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.